ETRA

Electra Therapeutics Inc

8.37

Oct 26 • 3:59 PM ET -0.34 (-3.90%)

8.37

Aftermarket • 7:30 PM ET 0.00 (0.00%)

Healthcare Biotechnology USA Small NASD

Peers: ALXO ANAB ACRS ALMS CLDX XNCR UPB IMVT SYRE ABVX

| Held by: VTI VXF VTWO TMED VTWG VTWV VTHR

Index	-
Market Cap	525.38M
Enterprise Value	-
Income	-
Sales	-
Book/sh	-
Cash/sh	-
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	-
IPO	Sep 18, 2026

P/E	-
Forward P/E	-
PEG	-
P/S	-
P/B	-
P/C	-
P/FCF	-
EV/EBITDA	-
EV/Sales	-
Quick Ratio	-
Current Ratio	-
Debt/Eq	-
LT Debt/Eq	-
Option/Short	No / Yes

EPS (ttm)	-
EPS next Y	-
EPS next Q	-0.45
EPS this Y	-
EPS next Y	-
EPS next 5Y	-
EPS past 3/5Y	- -
Sales past 3/5Y	- -
EPS Y/Y TTM	-
Sales Y/Y TTM	-
EPS Q/Q	-
Sales Q/Q	-
Earnings	Sep 02
EPS/Sales Surpr.	- -

Insider Own	38.62%
Insider Trans	12.36%
Inst Own	8.74%
Inst Trans	2.66%
ROA	-
ROE	-
ROIC	-
Gross Margin	-
Oper. Margin	-
Profit Margin	-
SMA20	-10.82%
SMA50	-18.08%
SMA200	-18.08%
Trades

Shs Outstand	62.77M
Shs Float	38.52M
Short Float	1.82%
Short Ratio	0.99
Short Interest	0.70M
52W High	15.50 -46.00%
52W Low	8.50 -1.53%
Volatility	6.86% 8.80%
ATR (14)	0.90
RSI (14)	24.89
Beta	-
Rel Volume	0.22
Avg Volume	707.76K
Volume	159,136

Perf Week	-2.79%
Perf Month	-27.53%
Perf Quarter	-
Perf Half Y	-
Perf YTD	-44.20%
Perf Year	-
Perf 3Y	-
Perf 5Y	-
Perf 10Y	-
Recom	1.00
Target Price	33.50
Prev Close	8.71
Price	8.37
Change %	-3.90%

Date	Action	Analyst	Rating Change	Price Target Change
Today	Initiated	H.C. Wainwright	Buy	$30
Oct-22-26	Initiated	JP Morgan	Overweight	$36
Oct-13-26	Initiated	TD Cowen	Buy
Oct-13-26	Initiated	Jefferies	Buy	$32
Oct-13-26	Initiated	Evercore ISI	Outperform	$36
Oct-13-26	Initiated	Cantor Fitzgerald	Overweight

Sep-30-26 08:23AM

Oura Shows How Shaky the IPO Market Really Is

(Barrons.com)

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
GORDON CARL L	Director	Sep 21 '26	Buy	15.00	1,333,333	19,999,995	5,126,891	Sep 23 05:35 PM
ORBIMED ADVISORS LLC	Director	Sep 21 '26	Buy	15.00	1,333,333	19,999,995	5,126,891	Sep 23 05:29 PM

Electra Therapeutics, Inc. is a clinical stage biotechnology company. It is engaged in therapies against novel targets for diseases in immunology and cancer. The company was founded by Adam Rosenthal on October 11, 2018 and is headquartered in South San Francisco, CA.

Pharm.D.Dr. Quehuong Dong M.B.A.

Chief Technology OfficerMr. Gary S. Koe Ph.D.

Ph.D.Dr. Kim-Hien Dao D.O.

Chief Financial OfficerMr. Christopher William Clark C.F.A.

Senior VP of Finance & Principal Accounting OfficerMr. David J. Tucker

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

ETRA

Electra Therapeutics Inc

Upgrade your Finviz experience